Reference entry · N-acetylated ACTH fragment analog
Adamax
Also known as: N-acetyl Semax · Ac-Semax
- Class
- N-acetylated ACTH fragment analog
- Size
- 7 amino acids (N-terminal acetylation)
- Primary targets (literature)
- Same research context as Semax (neurotrophin literature)
- Regulatory context
- Not FDA-approved. Catalog naming (Adamax vs. N-acetyl Semax) is inconsistent — sequence confirmation is mandatory.
Overview
Adamax commonly refers to an N-acetylated Semax variant sold in research catalogs. Acetylation alters N-terminal charge and may affect stability and permeability in model systems — it is a distinct chemical entity from unmodified Semax.
Mechanism in research literature
Mechanistic hypotheses inherit from Semax literature (neurotrophin and stress-response pathways) with additional pharmacokinetic interest around N-terminal acetylation in peptide stability research.
Common research focus areas
- N-acetylation vs. parent Semax sequence
- Stability and degradation in storage studies
- MS identity for acetylated heptapeptide
- Limited independent replication vs. Semax bibliography
Full literature roundup
Read the cited research summary
An N-acetylated Semax variant common in research catalogs. Terminal modification chemistry, stability literature, and identity verification vs. parent Semax.
Adamax research roundup · 6 minEvaluate catalog material
- COA literacy — read batch documentation before comparing vendors.
- Peptide identity testing — why sequence confirmation matters beyond purity %.
- How we vet sources — our score methodology for recommended vendors.